Clinical Schizophrenia & Related Psychoses · 2016 · 18 citations · 3 references
PharmacyPharmacologyPharmacotherapyAdult PsychiatryPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersTreatment-resistant Psychiatric DisordersAntipsychotic Medication ManagementAntipsychotic SafetyAntipsychotic-associated CardiotoxicityAtypical Antipsychotic TreatmentCardiac PathologyClozapine PharmacologyRechallenge ResponsesTherapeutic Rechallenge
Clozapine is an atypical antipsychotic which is often effective in patients who fail to respond to other antipsychotics, but its use carries substantial risk. Myocarditis is one of the life-threatening adverse effects, which occurs in about 1% of exposed patients. Rechallenge with clozapine is controversial, particularly shortly after the occurrence of the myocarditis, and when there is clear and convincing evidence of cardiac damage. Aggressive use of clozapine, however, may be critical for the recovery of patients early in the course of their illness. Here we report a successful case of clozapine rechallenge following an initial aggressive dosage titration in an inpatient setting.
3
Myocarditis and cardiomyopathy associated with clozapine
Jens Kilian, K. M. Kerr, Christopher Lawrence et al. · The Lancet · 1999 · 546 citations